{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:09:46Z","timestamp":1790208586295,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Anaesthesiology"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1016\/j.bpa.2003.09.012","type":"journal-article","created":{"date-parts":[[2003,10,31]],"date-time":"2003-10-31T15:29:15Z","timestamp":1067614155000},"page":"519-533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Malignant hyperthermia"],"prefix":"10.1016","volume":"17","author":[{"given":"Syed Z","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpa.2003.09.012_BIB1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/(SICI)1097-4598(200001)23:1<4::AID-MUS3>3.0.CO;2-D","article-title":"Genetics and pathogenesis of malignant hyperthermia","volume":"23","author":"Jurkat-Rott","year":"2000","journal-title":"Muscle and Nerve"},{"key":"10.1016\/j.bpa.2003.09.012_BIB2","first-page":"1479","article-title":"Abnormal uptake and release of Ca2+ ions from human malignant hyperthermia-susceptible sarcoplasmic reticulum","volume":"61","author":"O'Sullivan","year":"2001","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.bpa.2003.09.012_BIB3","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D","article-title":"Ryanodine receptor mutations in malignant hyperthermia and central core disease","volume":"15","author":"McCarthy","year":"2000","journal-title":"Human Mutation"},{"key":"10.1016\/j.bpa.2003.09.012_BIB4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1365-201x.2001.00840.x","article-title":"Malignant hyperthermia and excitation\u2013contraction coupling","volume":"171","author":"Melzer","year":"2001","journal-title":"Acta Anaesthesiologica Scandinavica"},{"key":"10.1016\/j.bpa.2003.09.012_BIB5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0140-6736(60)92690-8","article-title":"Anaesthetic deaths in a family (letter)","volume":"2","author":"Denborough","year":"1960","journal-title":"Lancet"},{"key":"10.1016\/j.bpa.2003.09.012_BIB6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/bja\/34.6.395","article-title":"Anaesthetic deaths in a family","volume":"34","author":"Denborough","year":"1962","journal-title":"British Journal of Anaesthesia"},{"key":"10.1016\/j.bpa.2003.09.012_BIB7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/bmj.1.5691.275","article-title":"Malignant hyperpyrexia during anaesthesia: possible association with subclinical myopathy","volume":"1","author":"Isaacs","year":"1970","journal-title":"British Medical Journal"},{"issue":"7679","key":"10.1016\/j.bpa.2003.09.012_BIB8","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(70)92069-6","article-title":"Metabolic error of muscle metabolism after recovery from malignant hyperthermia","volume":"2","author":"Kalow","year":"1970","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.bpa.2003.09.012_BIB9","first-page":"721","article-title":"Halothane-induced muscle contracture as a cause of hyperpyrexia","volume":"43","author":"Ellis","year":"1971","journal-title":"British Journal of Anaesthesia"},{"key":"10.1016\/j.bpa.2003.09.012_BIB10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/bja\/47.1.62","article-title":"Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium","volume":"47","author":"Harrison","year":"1975","journal-title":"British Journal of Anaesthesia"},{"key":"10.1016\/j.bpa.2003.09.012_BIB11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/0310057X7700500303","article-title":"Drug treatment of malignant hyperpyrexia","volume":"5","author":"Austin","year":"1977","journal-title":"Anaesthesia and Intensive Care"},{"key":"10.1016\/j.bpa.2003.09.012_BIB12","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00000542-198204000-00005","article-title":"Dantrolene in human malignant hyperthermia","volume":"56","author":"Kolb","year":"1982","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bpa.2003.09.012_BIB13","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0002-9343(98)00108-9","article-title":"Malignant hyperthermia and central core disease: disorders of Ca2+ release channels","volume":"104","author":"Loke","year":"1998","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.bpa.2003.09.012_BIB14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/pgmj.74.867.11","article-title":"Malignant hyperthermia","volume":"74","author":"Abraham","year":"1998","journal-title":"Postgraduate Medical Journal"},{"key":"10.1016\/j.bpa.2003.09.012_BIB15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00019052-199810000-00009","article-title":"The anesthetic myopathies and malignant hyperthermias","volume":"11","author":"Hogan","year":"1998","journal-title":"Current Opinion in Neurology"},{"issue":"5","key":"10.1016\/j.bpa.2003.09.012_BIB16","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00000542-200211000-00007","article-title":"Presence of two different genetic traits in malignant hyperthermia families: implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibility","volume":"97","author":"Monnier","year":"2002","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.bpa.2003.09.012_BIB17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF03005702","article-title":"Screening of malignant hyperthermia susceptible families by creatine phosphokinase measurement and other clinical investigations","volume":"23","author":"Britt","year":"1976","journal-title":"Canadian Anaesthetists' Society Journal"},{"key":"10.1016\/j.bpa.2003.09.012_BIB18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1213\/00000539-199308000-00014","article-title":"Malignant hyperthermia: a review of published cases","volume":"77","author":"Strazis","year":"1993","journal-title":"Anesthesia and Analgesia"},{"key":"10.1016\/j.bpa.2003.09.012_BIB19","first-page":"89","article-title":"The role of the skeletal muscle ryanodine receptor (RYR1) gene in malignant hyperthermia and central core disease","volume":"50","author":"MacLennan","year":"1995","journal-title":"Society of General Physiologists Series"},{"key":"10.1016\/j.bpa.2003.09.012_BIB20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF03007440","article-title":"Severe muscular rigidity at birth: malignant hyperthermia syndrome?","volume":"27","author":"Sewall","year":"1980","journal-title":"Canadian Anaesthetists' Society Journal"},{"key":"10.1016\/j.bpa.2003.09.012_BIB21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1213\/00000539-197901000-00011","article-title":"Management of suspected malignant hyperpyrexia in an infant","volume":"58","author":"Faust","year":"1979","journal-title":"Anesthesia and Analgesia"},{"issue":"3","key":"10.1016\/j.bpa.2003.09.012_BIB22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00000637-197805000-00013","article-title":"Malignant hyperthermia during repair of a cleft lip in a 6-month-old infant, with survival","volume":"1","author":"Dempsey","year":"1978","journal-title":"Annals of Plastic Surgery"},{"key":"10.1016\/j.bpa.2003.09.012_BIB23","first-page":"265","article-title":"Placental transfer of dantrolene (letter)","volume":"59","author":"Morison","year":"1983","journal-title":"Anesthesiology"},{"issue":"6258","key":"10.1016\/j.bpa.2003.09.012_BIB24","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/343559a0","article-title":"Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia","volume":"343","author":"MacLennan","year":"1990","journal-title":"Nature"},{"issue":"6258","key":"10.1016\/j.bpa.2003.09.012_BIB25","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/343562a0","article-title":"Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2","volume":"343","author":"McCarthy","year":"1990","journal-title":"Nature"},{"issue":"5 Pt 1","key":"10.1016\/j.bpa.2003.09.012_BIB26","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/BF03009870","article-title":"Malignant hyperthermia and calcium-induced heat production","volume":"41","author":"Ueda","year":"1994","journal-title":"Canadian Journal of Anaesthesia"},{"key":"10.1016\/j.bpa.2003.09.012_BIB27","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1016\/S0006-3495(98)77684-2","article-title":"Voltage-dependent calcium release in human malignant hyperthermia muscle fibers","volume":"75","author":"Struk","year":"1998","journal-title":"Biophysical Journal"},{"key":"10.1016\/j.bpa.2003.09.012_BIB28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0014-5793(83)80739-X","article-title":"Calcium-induced Ca2+ release from sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia. The effects of halothane and dantrolene","volume":"161","author":"Ohnishi","year":"1983","journal-title":"FEBS Letters"},{"key":"10.1016\/j.bpa.2003.09.012_BIB29","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1152\/physrev.1996.76.2.537","article-title":"Malignant hyperthermia: excitation\u2013contraction coupling. Ca2+ release channel, and cell Ca2+ regulation defects","volume":"76","author":"Mickelson","year":"1996","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.bpa.2003.09.012_BIB30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00000542-197601000-00008","article-title":"Halothane-induced porcine malignant hyperthermia: metabolic and hemodynamic changes","volume":"44","author":"Gronert","year":"1976","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bpa.2003.09.012_BIB31","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/336587a0","article-title":"Opening of dihydropyridine calcium channels in skeletal muscle membranes by inositol trisphosphate","volume":"336","author":"Vilven","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.bpa.2003.09.012_BIB32","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1126\/science.8047889","article-title":"Calcium and inositol 1,4,5-trisphosphate-induced Ca2+ release","volume":"265","author":"Combettes","year":"1994","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.bpa.2003.09.012_BIB33","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/bja\/78.5.541","article-title":"Inositol 1,4,5-trisphosphate in blood and skeletal muscle in human malignant hyperthermia","volume":"78","author":"Wappler","year":"1997","journal-title":"British Journal of Anaesthesia"},{"issue":"4","key":"10.1016\/j.bpa.2003.09.012_BIB34","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/BF00172783","article-title":"Hypersensitive response of malignant hyperthermia-susceptible skeletal muscle to inositol 1,4,5-triphosphate induced release of calcium","volume":"352","author":"Lopez","year":"1995","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"key":"10.1016\/j.bpa.2003.09.012_BIB35","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1399-6576.1993.tb03768.x","article-title":"Biochemical changes in malignant hyperthermia susceptible swine: cyclic AMP, inositol phosphates, alpha 1, beta 1- and beta 2-adrenoceptors in skeletal and cardiac muscle","volume":"37","author":"Scholz","year":"1993","journal-title":"Acta Anaesthesiologica Scandinavica"},{"issue":"1","key":"10.1016\/j.bpa.2003.09.012_BIB36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0014-2999(92)90016-W","article-title":"Increase of serotonin in plasma during onset of halothane-induced malignant hyperthermia in pigs","volume":"220","author":"Gerdes","year":"1992","journal-title":"European Journal of Pharmacology"},{"issue":"6","key":"10.1016\/j.bpa.2003.09.012_BIB37","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/BF00171727","article-title":"Pharmacodynamic effects of serotonin (5-HT) receptor ligands in pigs: stimulation of 5-HT2 receptors induces malignant hyperthermia","volume":"341","author":"Loscher","year":"1990","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"key":"10.1016\/j.bpa.2003.09.012_BIB38","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1097\/00000542-199606000-00002","article-title":"Effects of the serotonin2 receptor agonist DOI on skeletal muscle specimens from malignant hyperthermia-susceptible patients","volume":"84","author":"Wappler","year":"1996","journal-title":"Anesthesiology"},{"issue":"10","key":"10.1016\/j.bpa.2003.09.012_BIB39","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/j.1399-6576.1997.tb04650.x","article-title":"Attenuation of serotonin-induced contractures in skeletal muscle from malignant hyperthermia-susceptible patients with dantrolene","volume":"41","author":"Wappler","year":"1997","journal-title":"Acta Anaesthesiologica Scandinavica"},{"key":"10.1016\/j.bpa.2003.09.012_BIB40","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/00003643-200110000-00002","article-title":"Malignant hyperthermia","volume":"18","author":"Wappler","year":"2001","journal-title":"European Journal of Anaesthesiology"},{"key":"10.1016\/j.bpa.2003.09.012_BIB41","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00000542-199803000-00006","article-title":"The sensitivity and specificity of the caffeine\u2013halothane contracture test: a report from the North American Malignant Hyperthermia Registry. The North American Malignant Hyperthermia Registry of MHAUS","volume":"88","author":"Allen","year":"1998","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bpa.2003.09.012_BIB42","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1213\/00000539-200301000-00034","article-title":"Delayed onset of malignant hyperthermia in desflurane anesthesia","volume":"96","author":"Hoenemann","year":"2003","journal-title":"Anesthesia and Analgesia"},{"key":"10.1016\/j.bpa.2003.09.012_BIB43","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/bja\/60.3.274","article-title":"Malignant hyperthermia: biochemical aspects of the acute episode","volume":"60","author":"Heffron","year":"1988","journal-title":"British Journal of Anaesthesia"},{"issue":"1","key":"10.1016\/j.bpa.2003.09.012_BIB44","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00000542-199507000-00018","article-title":"Cardiovascular and metabolic responses to anesthetic-induced malignant hyperthermia in swine","volume":"83","author":"Roewer","year":"1995","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bpa.2003.09.012_BIB45","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/978-3-642-68569-9_17","article-title":"Malignant hyperthermia: a review","volume":"60","author":"Britt","year":"1982","journal-title":"Handbook of Experimental Pharmacology"},{"key":"10.1016\/j.bpa.2003.09.012_BIB46","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/0310057X9602400416","article-title":"Masseter spasm and elevated creatine kinase after intravenous induction in a child","volume":"24","author":"Habre","year":"1996","journal-title":"Anaesthesia and Intensive Care"},{"issue":"6","key":"10.1016\/j.bpa.2003.09.012_BIB47","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/00000542-199406000-00009","article-title":"Masseter muscle rigidity and malignant hyperthermia susceptibility in pediatric patients. An update on management and diagnosis","volume":"80","author":"O'Flynn","year":"1994","journal-title":"Anesthesiology"},{"issue":"11","key":"10.1016\/j.bpa.2003.09.012_BIB48","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1046\/j.1365-2044.1998.00562.x","article-title":"Suxamethonium, masseter spasm and later malignant hyperthermia","volume":"53","author":"Ramirez","year":"1998","journal-title":"Anaesthesia"},{"key":"10.1016\/j.bpa.2003.09.012_BIB49","first-page":"25","article-title":"Malignant hyperthermia","volume":"109","author":"Sessler","year":"1996","journal-title":"Acta Anaesthesiologica Scandinavica"},{"issue":"4","key":"10.1016\/j.bpa.2003.09.012_BIB50","first-page":"782","article-title":"Thermal response in acute porcine malignant hyperthermia","volume":"82","author":"Iaizzo","year":"1996","journal-title":"Anesthesia and Analgesia"},{"issue":"7","key":"10.1016\/j.bpa.2003.09.012_BIB51","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/BF03013392","article-title":"Metabolic events with spontaneous malignant hyperthermia crisis in an anaesthetized pig","volume":"44","author":"Kozak-Ribbens","year":"1997","journal-title":"Canadian Journal of Anaesthesia"},{"key":"10.1016\/j.bpa.2003.09.012_BIB52","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/00000542-199009000-00013","article-title":"Porcine malignant hyperthermia: critical temperatures for in vivo and in vitro responses","volume":"73","author":"Nelson","year":"1990","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bpa.2003.09.012_BIB53","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00000542-197602000-00004","article-title":"Porcine malignant hyperthermia induced by halothane and succinylcholine: failure of treatment with procaine or procainamide","volume":"44","author":"Gronert","year":"1976","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bpa.2003.09.012_BIB54","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00000542-197811000-00006","article-title":"Catecholamine stimulation of myocardial oxygen consumption in porcine malignant hyperthermia","volume":"49","author":"Gronert","year":"1978","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.bpa.2003.09.012_BIB55","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/jama.286.2.168","article-title":"Malignant hyperthermia and apparent heat stroke","volume":"286","author":"Tobin","year":"2001","journal-title":"Jama"},{"key":"10.1016\/j.bpa.2003.09.012_BIB56","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1046\/j.1442-2026.2001.00189.x","article-title":"Hyperpyrexia in the emergency department","volume":"13","author":"McGugan","year":"2001","journal-title":"Emergency Medicine (Fremantle, W.A.)"},{"issue":"1","key":"10.1016\/j.bpa.2003.09.012_BIB57","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/000992289703600102","article-title":"Hyperkalemic cardiac arrest during anesthesia in infants and children with occult myopathies","volume":"36","author":"Larach","year":"1997","journal-title":"Clinical Pediatrics (Philadelphia)"},{"issue":"5","key":"10.1016\/j.bpa.2003.09.012_BIB58","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/00000542-199711000-00013","article-title":"Efficacy of intraoperative cooling methods","volume":"87","author":"Plattner","year":"1997","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bpa.2003.09.012_BIB59","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF00501011","article-title":"Excitation\u2013contraction uncoupling in skeletal muscle by dantrolene sodium","volume":"274","author":"Ellis","year":"1972","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"key":"10.1016\/j.bpa.2003.09.012_BIB60","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2165\/00003495-198632020-00003","article-title":"Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity","volume":"32","author":"Ward","year":"1986","journal-title":"Drugs"},{"key":"10.1016\/j.bpa.2003.09.012_BIB61","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00000542-198004000-00003","article-title":"Dantrolene dose response in malignant hyperthermia-susceptible (MHS) swine: method to obtain prophylaxis and therapeusis","volume":"52","author":"Flewellen","year":"1980","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.bpa.2003.09.012_BIB62","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00000542-198310000-00002","article-title":"Dantrolene dose response in awake man: implications for management of malignant hyperthermia","volume":"59","author":"Flewellen","year":"1983","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bpa.2003.09.012_BIB63","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/bja\/52.1.11","article-title":"Porcine malignant hyperthermia. VII: Hepatic metabolism","volume":"52","author":"Hall","year":"1980","journal-title":"British Journal of Anaesthesia"},{"key":"10.1016\/j.bpa.2003.09.012_BIB64","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0022-3565(25)29823-8","article-title":"Site of action of dantrolene in frog sartorius muscle","volume":"189","author":"Putney","year":"1974","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.bpa.2003.09.012_BIB65","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archneur.1975.00490440042006","article-title":"Excitation\u2013contraction uncoupling. The effect of hyperosomolar glycerol solution and antrolene sodium on mammalian muscle in vitro","volume":"32","author":"Kurihara","year":"1975","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.bpa.2003.09.012_BIB66","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1126\/science.959824","article-title":"Calcium release from skeletal muscle sarcoplasmic reticulum: site of action of dantrolene sodium","volume":"193","author":"van Winkle","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.bpa.2003.09.012_BIB67","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/bja\/52.3.319","article-title":"Effects of temperature, adenosine triphosphate and magnesium concentrations on the contraction of actomyosin isolated from halothane-sensitive and -insensitive German Landrace pigs","volume":"52","author":"Green","year":"1980","journal-title":"British Journal of Anaesthesia"},{"issue":"5","key":"10.1016\/j.bpa.2003.09.012_BIB68","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1213\/00000539-199411000-00033","article-title":"Myoplasmic calcium changes precede metabolic and clinical signs of porcine malignant hyperthermia","volume":"79","author":"Ryan","year":"1994","journal-title":"Anesthesia and Analgesia"},{"issue":"8","key":"10.1016\/j.bpa.2003.09.012_BIB69","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1399-6576.1997.tb04820.x","article-title":"In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group","volume":"41","author":"Ording","year":"1997","journal-title":"Acta Anaesthesiologica Scandinavica"},{"key":"10.1016\/j.bpa.2003.09.012_BIB70","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/bja\/80.3.389","article-title":"Multicentre evaluation of ryanodine contracture testing in malignant hyperthermia. The European Malignant Hyperthermia Group","volume":"80","author":"Hopkins","year":"1998","journal-title":"British Journal of Anaesthesia"},{"key":"10.1016\/j.bpa.2003.09.012_BIB71","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00000542-200201000-00036","article-title":"Testing for malignant hyperthermia","volume":"96","author":"Rosenberg","year":"2002","journal-title":"Anesthesiology"},{"issue":"9317","key":"10.1016\/j.bpa.2003.09.012_BIB72","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(02)08506-9","article-title":"Diagnosis of susceptibility to malignant hyperthermia by use of a metabolic test","volume":"359","author":"Anetseder","year":"2002","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bpa.2003.09.012_BIB73","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/bja\/86.2.283","article-title":"Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia","volume":"86","author":"Urwyler","year":"2001","journal-title":"British Journal of Anaesthesia"},{"issue":"4","key":"10.1016\/j.bpa.2003.09.012_BIB74","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/bja\/64.4.425","article-title":"Prediction of malignant hyperthermia susceptibility: statistical evaluation of clinical signs","volume":"64","author":"Hackl","year":"1990","journal-title":"British Journal of Anaesthesia"},{"key":"10.1016\/j.bpa.2003.09.012_BIB75","first-page":"161","article-title":"Masseter muscle rigidity and malignant hyperthermia susceptibility","volume":"65","author":"Rosenberg","year":"1986","journal-title":"Anesthesia and Analgesia"},{"key":"10.1016\/j.bpa.2003.09.012_BIB76","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/bja\/51.10.949","article-title":"Retrospective analysis of anaesthetics received by patients before susceptibility to malignant hyperpyrexia was recognized","volume":"51","author":"Halsall","year":"1979","journal-title":"British Journal of Anaesthesia"}],"container-title":["Best Practice &amp; Research Clinical Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521689603000806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521689603000806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:25:58Z","timestamp":1776425158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521689603000806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":76,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S1521689603000806"],"URL":"https:\/\/doi.org\/10.1016\/j.bpa.2003.09.012","relation":{},"ISSN":["1753-3740"],"issn-type":[{"value":"1753-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Malignant hyperthermia","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Anaesthesiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpa.2003.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}